[
    [
        {
            "time": "",
            "original_text": "贝达药业(300558.SZ)：股东贝成投资解除质押756.8万股",
            "features": {
                "keywords": [
                    "贝达药业",
                    "股东",
                    "贝成投资",
                    "解除质押",
                    "756.8万股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：股东贝成投资解除质押756.8万股",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：20Q2主动公募医药持仓维持大幅超配状态 重仓集中度有所下降",
            "features": {
                "keywords": [
                    "医药生物",
                    "20Q2",
                    "主动公募",
                    "超配",
                    "重仓集中度",
                    "下降"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业：20Q2主动公募医药持仓维持大幅超配状态 重仓集中度有所下降",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "快讯：贝达药业跌停 报于133.21元",
            "features": {
                "keywords": [
                    "贝达药业",
                    "跌停",
                    "133.21元"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "快讯：贝达药业跌停 报于133.21元",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 10,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]